News & Events about Altimmune Inc.
Mr. Jordt brings over 25 years of industry experience in corporate strategy and business developmentGAITHERSBURG, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Raymond Jordt as Chief Business ...
GAITHERSBURG, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Stephen A. Harrison, Chairman and Co-Founder, Pinnacle Clinical Research and Summit Clinical Research, will deliver an oral presentation of the ...
Globe Newswire
2 months ago
GAITHERSBURG, Md., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Companys management team will participate at the following investor conferences: Evercore ISI 5th Annual HealthCONx Virtual ...
Globe Newswire
3 months ago
GAITHERSBURG, Md., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the Company will be presenting at two upcoming scientific conferences in November 2022: American Heart Association Scientific Sessions 2022, Chicago, ...
Thinking about buying stock in Imara, Nutanix, Azul, 22nd Century Group, or Altimmune? Thinking about buying stock in Imara, Nutanix, Azul, 22nd Century Group, or Altimmune? PR Newswire NEW YORK, Oct. 14, 2022 NEW YORK, Oct. 14, 2022 /PRNewswire/ -- InvestorsObserverissues critical PriceWatch...